PROFUSA, INC. Marketable Securities (Non-Current)
PROFUSA, INC. (PFSA) had Marketable Securities (Non-Current) of $8.48 million as of 2024-06-30, per its 10-Q filed 2024-11-15.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:MarketableSecuritiesNoncurrent · last filed 2024-11-15
- 2024-06-30: Marketable Securities, Noncurrent $8.48M.
- 2024-03-31: Marketable Securities, Noncurrent $8.43M.
- 2023-12-31: Marketable Securities, Noncurrent $10.87M.
| Period end | Marketable Securities, Noncurrent |
|---|---|
| 2024-06-30 | $8.48M 10-Q · filed 2024-11-15 |
| 2024-03-31 | $8.43M 10-Q · filed 2024-10-09 |
| 2023-12-31 | $10.87M 10-Q · filed 2024-11-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Tenon Medical, Inc. (TNON) | United States | $0.002B | |
| Catheter Precision, Inc. (VTAK) | United States | $0.002B | -0.23 |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Bluejay Diagnostics, Inc. (BJDX) | United States | $0.004B |